Antibiotic resistance is one of the biggest challenges to public health. It threatens our progress in healthcare, food production, and, ultimately, life expectancy. Researchers from the University of Geneva have discovered that edoxudine, an anti- herpes molecule, can weaken the protective surface of Klebsiella bacteria responsible for causing infections, making it easier to eliminate them from the immune system. K.
pneumoniae is an opportunistic pathogen that is typically acquired in hospitals in patients with impaired immunity. However, community-acquired infections are also common. The virulence of Klebsiella pneumoniae stems from its ability to evade attacks from immune cells, causing fatalities in 40% – 50% of infected people. Unlike other antibiotics , edoxudine doesn’t kill bacteria; instead, it weakens their protective surface, which limits the risk of developing resistance.…
